Latest News : 2013 : December

The NASDAQ welcomes Eckhard Podack, M.D., Ph.D., outside Times Square in New York City, as Heat Biologics makes its initial public offering.

U Innovation Celebrates First Public Offering of a University of Miami Spin-Off

U Innovation, home of technology advancement at the University of Miami, is celebrating the first initial public offering (IPO) by a company to evolve from its mission to bring life-enhancing discoveries made by UM scientists to the marketplace. The company, Heat Biologics (NASDAQ: HTBX), raised $27 million to fund clinical trials for its proprietary, unique off-the-shelf ImPACT (Immune Pan Antigen Cytotoxic Therapy) vaccines.

Read more »